Journal of Jilin University(Medicine Edition) ›› 2022, Vol. 48 ›› Issue (6): 1437-1447.doi: 10.13481/j.1671-587X.20220609
• Research in basic medicine • Previous Articles Next Articles
Junxiu LIU1,Jia ZHOU1,Guangfu LYU2,Yuchen WANG1,Xuefeng ZHUANG1,Jiarui ZHAO1,Xiaowei HUANG1(
),Ruili LI1(
)
Received:2022-03-29
Online:2022-11-28
Published:2022-12-07
Contact:
Xiaowei HUANG,Ruili LI
E-mail:15948000740@163.com;377311060@qq.com
CLC Number:
Junxiu LIU,Jia ZHOU,Guangfu LYU,Yuchen WANG,Xuefeng ZHUANG,Jiarui ZHAO,Xiaowei HUANG,Ruili LI. Protective effect of Shenhong Buxue Granule on vascular endothelium of mice with vascular endothelial dysfunction of Qi stagnation and blood stasis type and its mechanism[J].Journal of Jilin University(Medicine Edition), 2022, 48(6): 1437-1447.
Tab. 1
Behavioral performance of mice in various groups"
| Group | Grasping forcevalue(m/g) | Number of autonomous activity |
|---|---|---|
| Normal control | 263.22±76.51 | 53.17±5.21 |
| VED | 158.67±37.34* | 35.00±7.96** |
| Positive control | 262.15±43.91△△ | 50.83±6.57△△ |
| SBG | ||
| Low dose | 210.75±32.47△ | 41.83±5.43 |
| Middle dose | 229.82±23.01△△ | 44.00±9.63 |
| High dose | 255.18±20.17△△ | 48.67±9.74△ |
Tab. 2
Whole blood viscosities of mice in various groups (n=10,x±s,mPa·s)"
| Group | Whole blood viscosity | |||
|---|---|---|---|---|
| 10·s-1 | 60·s-1 | 150·s-1 | ||
| Normal control | 8.45±1.24 | 5.84±0.82 | 4.44±0.69 | |
| VED | 16.23±4.42** | 9.63±2.81* | 7.37±2.62* | |
| Positive control | 8.55±2.27△△ | 6.59±0.74△ | 4.57±0.49△ | |
| SBG | ||||
| Low dose | 10.49±1.67△ | 6.55±0.66△ | 4.60±0.61△ | |
| Middle dose | 9.85±1.65△ | 6.26±1.28△ | 4.59±0.50△ | |
| High dose | 9.60±0.60△△ | 6.03±1.26△ | 4.55±0.63△ | |
Tab. 3
Levels of serum vWF,TM,ICAM-1,and NO of mice in various groups"
| Group | vWF [λB/(U·L-1)] | TM [ρB/(pg·L-1)] | ICAM-1 [ρB/(ng·L-1)] | NO [cB/(μmol·L-1)] | |
|---|---|---|---|---|---|
| Normal control | 255.53±44.10 | 18.11±2.37 | 184.01±8.32 | 26.40±2.09 | |
| VED | 486.13±82.92* | 25.83±2.73* | 240.10±1.36** | 16.08±2.09** | |
| Positive control | 262.53±45.90△ | 19.63±1.49△ | 197.79±5.50△△ | 24.93±2.09△ | |
| SBG | |||||
| Low dose | 353.53±47.39 | 23.11±1.24 | 230.48±8.49 | 16.08±4.17 | |
| Middle dose | 334.87±94.10 | 22.69±1.51 | 212.53±1.63△△ | 19.03±3.61 | |
| High dose | 290.87±47.23△ | 18.58±1.92△ | 211.25±7.85△△ | 21.98±2.09△ |
Tab. 4
Levels of TNF-α and IL-6 in serum and activities of GSH-Px and SOD in thoracic aorta tissue of mice in various groups (n=10,x±s)"
| Group | TNF-α [ρB/(ng·L-1)] | IL-6 [ρB/(pg·L-1)] | GSH-Px [λB/(U·mg-1)] | SOD [λB/(U·mg-1)] | |
|---|---|---|---|---|---|
| Normal control | 626.88±127.88 | 54.62±11.83 | 260.81±12.79 | 52.09±2.43 | |
| VED | 1 006.04±96.97* | 100.40±15.85* | 150.35±6.68** | 32.96±2.97** | |
| Positive control | 652.92±99.49△ | 57.68±13.95△ | 232.50±10.40△△ | 42.74±2.02△ | |
| SBG | |||||
| Low dose | 718.54±112.45 | 72.30±8.53 | 182.22±7.84 | 34.87±2.54 | |
| Middle dose | 688.33±128.50△ | 70.79±6.66 | 187.06±19.76 | 38.51±1.91 | |
| High dose | 656.46±121.80△ | 57.55±13.75△ | 229.52±19.73△△ | 43.54±1.33△ |
Tab. 5
Levels of TNF-α,IL-6,LDH,MDA,NO and activities of GSH-Px and SOD in HUVECs in various groups"
| Group | TNF-α [ρB/(ng·L-1)] | IL-6 [ρB/(pg·L-1)] | NO [cB/(μmol·L-1)] | LDH [λB/(U·L-1)] | MDA [mB/(μmol·g-1)] | GSH-PX [λB/(U·mg-1)] | SOD [λB/(U·mg-1)] |
|---|---|---|---|---|---|---|---|
| Normal control | 66.97±4.35 | 39.65±5.33 | 27.88±6.26 | 202.78±60.48 | 2.13±0.21 | 203.67±11.62 | 40.12±1.88 |
| TBHP | 135.27±9.87** | 98.60±6.80** | 14.44±0.23* | 495.37±65.21* | 5.15±0.44** | 115.35±4.44** | 18.62±1.14** |
| SBG | |||||||
| Low dose | 122.72±6.97 | 82.07±5.38 | 19.03±3.61 | 400.93±68.61 | 3.92±0.22* | 139.93±12.44 | 21.58±1.98 |
| Middle dose | 102.14±6.33△ | 72.64±8.17△ | 21.98±2.09△△ | 309.26±47.39△ | 3.39±0.25△△ | 152.74±10.18△△ | 30.52±2.27△△ |
| High dose | 78.52±4.90△△ | 53.61±10.78△△ | 23.45±3.61△ | 243.06±80.64△ | 2.87±0.25△△ | 185.77±8.04△△ | 36.04±3.18△△ |
Tab. 6
Survival rates of HUVECs in various groups"
| Group | Survival rate |
|---|---|
| Normal control | |
| 5% blank serum | 100.00±0.00 |
| 10% blank serum | 100.00±0.00 |
| 20% blank serum | 100.00±0.00 |
| Low dose of SBG | |
| 5% drug serum | 95.75±5.55 |
| 10% drug serum | 98.08±1.15 |
| 20% drug serum | 93.63±3.32 |
| Middle dose of SBG | |
| 5% drug serum | 99.04±3.86 |
| 10% drug serum | 95.68±2.56* |
| 20% drug serum | 86.39±5.78* |
| High dose of SBG | |
| 5% drug serum | 99.84±3.93 |
| 10% drug serum | 85.17±0.40* |
| 20% drug serum | 70.54±7.36* |
Tab. 8
Expression levels of TLR4, MyD88,NF-κB p65, and ICAM-1 proteins in HUVECs in various groups"
| Group | TLR4 | MyD88 | NF-κB p65 | ICAM-1 |
|---|---|---|---|---|
| Normal control | 1.00±0.00 | 1.00±0.00 | 1.00±0.00 | 1.00±0.00 |
| TBHP | 1.72±0.21** | 1.88±0.31* | 1.97±0.24** | 2.18±0.39* |
| SBG | ||||
| Low dose | 1.63±0.13 | 1.74±0.29 | 1.81±0.23 | 1.86±0.17 |
| Middle dose | 1.55±0.24△ | 1.79±0.37 | 1.99±0.36 | 1.76±0.27 |
| High dose | 1.16±0.04△ | 1.24±0.11△ | 1.34±0.08△ | 1.22±0.10△ |
| 1 | 陈博欣, 汤雪纯, 郝二伟. 现代名中医治疗动脉粥样硬化的用药规律研究[J]. 中医临床研究, 2017, 9(27): 31-34. |
| 2 | AL-QURAISHY S, OTHMAN M S, DKHIL M A, et al. Olive (Olea europaea) leaf methanolic extract prevents HCl/ethanol-induced gastritis in rats by attenuating inflammation and augmenting antioxidant enzyme activities[J]. Biomed Pharmacother, 2017, 91: 338-349. |
| 3 | 刘文斌, 徐 岩, 李智萌, 等. 参红补血颗粒对血虚证小鼠肾脏组织中EPO mRNA和骨髓组织中GM-CSF mRNA表达水平的影响[J]. 吉林大学学报(医学版), 2017, 43(3): 538-542. |
| 4 | 徐 岩, 曲晓波, 黄晓巍, 等. 参红补血颗粒对失血性血虚模型小鼠骨髓细胞周期及肾脏TNF-α表达的影响[J]. 中华中医药杂志, 2018, 33(7): 2773-2776. |
| 5 | FEI Y X, ZHAO B, YIN Q Y, et al. Ma xing Shi Gan Decoction attenuates PM2.5 induced lung injury via inhibiting HMGB1/TLR4/NF-κB signal pathway in rat[J]. Front Pharmacol, 2019, 10: 1361. |
| 6 | 郭文鹤, 黄娜娜, 张晓亮, 等. 动脉粥样硬化(气滞血瘀证)病证结合大鼠模型的研究[J]. 中国比较医学杂志, 2019, 29(9): 32-41. |
| 7 | 王婷婷, 贾 乘, 陈 宇, 等. 大鼠气滞血瘀证模型的建立及影响因素分析[J].中国中药杂志,2012,37(11): 1629-1633. |
| 8 | HUANG Y X, XU D Q, YUE S J, et al. Deciphering the active compounds and mechanisms of qixuehe capsule on qi stagnation and blood stasis syndrome: a network pharmacology study[J]. Evid Based Complement Alternat Med, 2020, 2020: 5053914. |
| 9 | WANG Y Q, YAN J Y, LI S X, et al. Composition of the essential oil from Danggui-Zhiqiao herb-pair and its analgesic activity and effect on hemorheology in rats with blood stasis syndrome[J]. Pharmacogn Mag, 2016, 12(48): 271-275. |
| 10 | 刘校彤, 吕光华, 王巧稚, 等. 血瘀证动物模型制备的研究进展[J].中国实验动物学报,2021,29(3):371-380. |
| 11 | 郝晓慧, 赵明中, 张玉芝, 等. 过表达E1A激活基因阻遏子对OxLDL诱导的血管内皮细胞损伤的影响[J].郑州大学学报(医学版),2019,54(2):258-262. |
| 12 | LENG B, TANG F T, LU M L, et al. Astragaloside Ⅳ improves vascular endothelial dysfunction by inhibiting the TLR4/NF-κB signaling pathway[J]. Life Sci, 2018, 209: 111-121. |
| 13 | 张城林, 何 蕾, 王 力, 等. 内皮功能障碍的发生机制[J]. 中国科学: 生命科学, 2022, 52(5): 691-698. |
| 14 | ZHAI Z H, OUYANG W, YAO Y J, et al. Dexamethasone-loaded ROS-responsive poly(thioketal) nanoparticles suppress inflammation and oxidative stress of acute lung injury[J]. Bioact Mater, 2022, 14: 430-442. |
| 15 | 张泽华, 冷玉琳, 杨 婵, 等. 基于“亢害承制”理论探讨内皮功能障碍对糖尿病大血管病变的影响[J]. 中国实验方剂学杂志, 2022, 28(4): 227-234. |
| 16 | NIE Q, ZHU L P, ZHANG L J, et al. Astragaloside Ⅳ protects against hyperglycemia-induced vascular endothelial dysfunction by inhibiting oxidative stress and Calpain-1 activation[J]. Life Sci, 2019, 232: 116662. |
| 17 | MO J, YANG R H, LI F, et al. Scutellarin protects against vascular endothelial dysfunction and prevents atherosclerosis via antioxidation[J]. Phytomedicine, 2018, 42: 66-74. |
| 18 | 金海南, 刘莉园, 金芳多, 等. 祁州漏芦水提取物对叔丁基过氧化氢诱导血管内皮细胞损伤的保护作用[J]. 中国药学杂志, 2018, 53(16): 1366-1372. |
| 19 | 刘莉园, 张 天, 张 钊, 等. 草苁蓉多糖对氧化损伤致血管内皮细胞凋亡相关蛋白表达的影响[J]. 食品研究与开发, 2020, 41(22): 162-168. |
| 20 | DU X H, CHEN Q J, SONG J B, et al. Rhubarb-aconite Decoction (RAD) drug-containing serum alleviated endotoxin-induced oxidative stress injury and inflammatory response in caco-2 cells in vitro [J]. Evid Based Complement Alternat Med, 2020, 2020: 5834502. |
| 21 | YU J, XIA F, LI X, et al. Effects of Qingguang’an containing serum on the expression levels of autophagy-related genes in human Tenon’s fibroblasts induced by transforming growth factor beta 1[J]. J Tradit Chin Med, 2021, 41(2): 236-245. |
| 22 | HURKS R, VINK A, HOEFER I E, et al. Atherosclerotic risk factors and atherosclerotic postoperative events are associated with low inflammation in abdominal aortic aneurysms[J]. Atherosclerosis, 2014, 235(2): 632-641. |
| 23 | AKSEH S, NEMATI M, ZAMANI-GHAREHCHAMANI E, et al. Amnion membrane proteins attenuate LPS-induced inflammation and apoptosis by inhibiting TLR4/NF-κB pathway and repressing microRNA-155 in rat H9c2 cells[J]. Immunopharmacol Immunotoxicol,2021,43(4):487-494. |
| 24 | SEIF M, DEABES M, EL-ASKARY A, et al. Ephedra sinica mitigates hepatic oxidative stress and inflammation via suppressing the TLR4/MyD88/NF-κB pathway in fipronil-treated rats[J]. Environ Sci Pollut Res Int, 2021, 28(44): 62943-62958. |
| 25 | HU Z P, FANG X L, FANG N, et al. Melatonin ameliorates vascular endothelial dysfunction, inflammation, and atherosclerosis by suppressing the TLR4/NF-κB system in high-fat-fed rabbits[J]. J Pineal Res, 2013, 55(4): 388-398. |
| 26 | 朱建丽, 张娜娜, 刘小菊. 酸枣仁皂苷A下调TLR/NF-κB通路改善高脂肥胖幼鼠血管内皮功能障碍[J]. 中国新药与临床杂志, 2020, 39(6): 374-380. |
| 27 | 冷 彬. 黄芪甲苷通过TLR4/NF-κB信号通路改善血管内皮功能障碍[D]. 锦州: 锦州医科大学, 2019. |
| 28 | 李嘉慧, 王欣佩, 冷 静. TLR4/NF-κB参与动脉粥样硬化发生发展机制的研究进展[J]. 中国比较医学杂志, 2021, 31(4): 137-142. |
| 29 | 杨利斌, 杨 林, 王善坤, 等. miR-155对IL-1β诱导髓核细胞凋亡、炎症和氧化应激的影响[J]. 安徽医科大学学报, 2020, 55(7): 1046-1051. |
| [1] | Lina XU,Xiaoshuang HE,Wenyan XIN,Chao WU. Improvement effect of bone marrow mesenchymal stem cell-derived exosomes on airway resistance and lung tissue lesion in mice of asthmatic models and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2026, 52(3): 602-611. |
| [2] | Lingyu WANG,Ruili LI,Yu ZHANG,Meitong GUO,Yalong LIANG,Xu HAN,Xiaowei HUANG,Yang ZHANG,Xiuhua YU. Improvement effect of Renshen Jianzhi Tablets on learning and memory ability in cognitive impairment model rats and its protective effect on hippocampal neurons and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2026, 52(3): 719-729. |
| [3] | Zheng TANG,Wei LIU,Hongmin HU,Qi LAI,Yan SHI,Shengquan LIU,Jun YANG,Chun CHU. Improvement effect of Qishen Yiqi dropping pills on myocardium injury in rats induced by sorafenib and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2026, 52(2): 308-317. |
| [4] | Ning MA,Shuang LIU,Chengyao WANG,Jiajun LU,Linyu CHEN,Ziyi WANG,Weiqin ZHAO,Weitong WANG,Pengcheng CHE,Hong SUN. Improvement effect of topical application of exosome loaded hydrogel DCC on peritoneal adhesion in mice and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2026, 52(2): 318-329. |
| [5] | Aimei LI,Jingfei HAN,Li DENG,Siyu CHEN. Protective effect of dexmedetomidine on myocardial injury in myocardial ischemia/reperfusion injury model rats [J]. Journal of Jilin University(Medicine Edition), 2026, 52(2): 451-459. |
| [6] | Ziyi TANG,Shiying YANG,Tianzhen YANG,Wenqiang LIU,Jiangxue ZHONG,Li YIN. Induction effect of pesticide pyraclostrobin on ferroptosis of spermatocytes GC-2 of mice [J]. Journal of Jilin University(Medicine Edition), 2026, 52(1): 18-25. |
| [7] | Sitong CHEN,Dan YANG,Qingjie LI,Xiaolei TANG,Han WANG,Yangyang LIU,Tiejun LIU. Ameliorative effect of puerarin on non-alcoholic fatty liver disease induced by high-fat diet in mice and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2026, 52(1): 44-55. |
| [8] | Jing LIU,Yan WANG,Xu HUANG. Promoting effect of overexpressed circRNAs-modified dental pulp stem cell-derived exosomes on angiogenesis of human umbilical vein endothelial cells [J]. Journal of Jilin University(Medicine Edition), 2025, 51(6): 1561-1570. |
| [9] | Yi ZHAO,Bing ZHOU,Huirui QIU,Xuan LI,Xiangli CUI. Improvement effect of lovastatin on hyperlipidemia-induced liver injury in rats and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2025, 51(5): 1155-1164. |
| [10] | Nan LU,Mingxin DONG,Lei YU,Chengbiao SUN,Yan WANG,Na XU,Wensen LIU,Shumin GE. Transcriptome sequencing-based expression profiling of oxidative stress-related genes and circRNAs in ricin toxin-induced macrophage pyroptosis [J]. Journal of Jilin University(Medicine Edition), 2025, 51(4): 1007-1018. |
| [11] | Yue WANG,Ning MA,Jiajun LU,Chengyao WANG,Linyu CHEN,Yuchen REN,Jingwu LI,Hong SUN. Protective effect of novel composite hydrogels on H₂O₂-induced oxidative stress injury in cardiomyocytes [J]. Journal of Jilin University(Medicine Edition), 2025, 51(2): 352-359. |
| [12] | Chaohe ZHANG,Xinwei ZHANG,Xiangfeng WANG. Protective effect of Pien-Tze-Huang on acetaminophen-induced liver injury and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2025, 51(1): 105-114. |
| [13] | Yanyan BAI,Yutong ZHOU,Haijuan SUI,Zhuo LIU. Improvement effect of asiatic acid on damage of lipopolysaccharide-induced hippocampum neuron in rats through Nrf2/HO-1 signaling pathway [J]. Journal of Jilin University(Medicine Edition), 2025, 51(1): 85-95. |
| [14] | Siqi LI,Guangdao CHEN,Qiyi ZENG. Improvement effect of chrysophanol on hydrogen peroxide-induced apoptosis of EA. hy926 cells and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2024, 50(6): 1512-1518. |
| [15] | Meng QU,Rui HUANG,Xinda JU,Yuxin LIU,Jichen XIA,Jiaxin HUANG,Chunyan YU,Zhiheng DONG. Ameliorative effect of ginsenoside Rh1 on kidney injury in diabetic mice through activation of Nrf2/HO-1 signaling pathway [J]. Journal of Jilin University(Medicine Edition), 2024, 50(6): 1565-1571. |
|